MEI Pharma Inc. (NASDAQ:MEIP)'s traded shares stood at 0.57 million during the last session, with the company's beta value hitting 1.44. The MEIP stock pric The information in this preliminary prospectus supplement is not complete and may be changed. MEI Pharma Prices Common Stock Offering at $2.60 Per Share. A company's earnings reviews provide a brief indication of a stock's direction in the short term, where in the case of MEI Pharma Inc. 1 upward and no downward comments were posted in the last 7 days. MEI PHARMA, INC. : MEIP Stock Price | US55279B2025 ... Mei Pharma Target Price for January 2022 | MEIP MEI Pharma, Inc. (NASDAQ:MEIP) is possibly approaching a major achievement in its business, so we would like to shine some light on the company.MEI Pharma, Inc., a late-stage pharmaceutical company, focuses on the development and commercialization of various therapies for the treatment of cancer. Their forecasts range from $8.00 to $20.00. MEIP | MEI Pharma Inc. Analyst Estimates & Rating - WSJ On average, analysts forecast that GERN's EPS will be $-0.42 for 2022, with the lowest EPS forecast at $-0.55, and the highest EPS forecast at $-0.33. Biotechs industry in the US expected to see average net income decline 10.0% next year. On PennyStocks.com you will find a comprehensive list of Penny Stocks & discover the Best Penny Stocks to buy, top penny stock news, and micro-cap stock articles. Lucid doesn't expect to be cash-flow positive until 2025 with new models coming on stream in 2022 and 2023 and plans to launch a rival to Teslas Model 3 in 2024-2025 . The Company is focused on development and commercialization of novel cancer therapies. 52wk High 2.55. on MEIP's analyst rating history. View analysts' price targets for MEI Pharma or view top-rated stocks among Wall Street analysts. For long-term investors, stocks are a good investment even during periods of the market volatility - a stock market downturn means that many stocks are on sale. MT Newswires. Learn more. MEI Pharma (NASDAQ:MEIP) has priced the public offering of 17.5M shares of its common stock at $2.60/share for total gross proceeds of $45.5M. Issued By Truist Securiti (NASDAQ:MEIP) The stock is at the lower part of a very wide and horizontal trend in the short term, and normally this may pose a good buying opportunity, though a breakdown through the bottom trend line at $2.45 will give a strong sell signal and a trend shift may be expected.. Get prepared with the key expectations. A registration statement relating to the securities has . Valco Finny, 28 July 2020 Add to Watchlist. Price trends tend to persist, so it's worth looking at them when it comes to a share like MEI Pharma Inc. Over the past six months, the relative strength of its shares against the market has been -23.67% . . The best long-term & short-term Magnite share price prognosis for 2021, 2022, 2023, 2024, 2025, 2026 with daily . MEI Pharma Announces Pricing of Public Offering of Common Stock. Its Zandelisib is an oral phosphatidylinositol 3-kinase . Low EPS Forecast High EPS Forecast; Jun 2022 9 $-0.54 $-0.70 $-0.06 . MEI Pharma. The average Micron Technology stock forecast 2022 represents a 22.35% increase from the last price of $84.3499984741211. 2022 revenue forecast decreased from US$55.0m to US$38.1m. View Mei Pharma earnings report, earnings release announcements 2021 , EPS and history data. . MEI Pharma, Inc. (Nasdaq: MEIP), a late-stage pharmaceutical company focused on advancing new therapies for cancer, announced today that it plans to offer 17,500,000 shares of its common stock in an underwritten. Today MEIP stock price opened at $2.98 after previous close of $3.02. The Company's portfolio of clinical drug candidates includes Zandelisib (f/k/a ME-401), Voruciclib, ME-344, and Pracinostat. SAN DIEGO, December 02, 2021--MEI Pharma, Inc. (Nasdaq: MEIP), a late-stage pharmaceutical company focused on advancing new . Penny Stocks (PennyStocks.com) is the top online destination for all things Micro-Cap Stocks. -TIDAL Study Data on Track to be Reported by End of Calendar Year 2021--MEI Begins Second Fiscal Quarter with ~$145.5 Million in Cash-SAN DIEGO, November 10, 2021--(BUSINESS WIRE)--MEI Pharma, Inc. (NASDAQ: MEIP), a late-stage pharmaceutical company focused on advancing new therapies for cancer, today reported results for the quarter ended September 30, 2021 and highlighted recent corporate . 333-238056. Data is currently not available. Medpace Holdings (MEDP) stock price prediction is 382.97435962378 USD. MEIP | Complete MEI Pharma Inc. stock news by MarketWatch. On market down days there are always outliers bucking the overall trend and as the main indexes took a beating on Tuesday, it was MEI . The current stock price of Mei Pharma (NASDAQ:MEIP) is $2.91. The target implies an upside of 77 . Staying with the analyst view, there is a consensus estimate of $52.27 million for the company's annual revenue in 2022. DiDi stock forecast 2025 On June 30, Atlantic Equities analyst Xiao Ai initiated coverage of DiDi Global with an overweight rating and a target price of $25. As of 2021 December 26, Sunday current price of MEIP stock is 2.570$ and our data indicates that the asset price has been in a downtrend for the past 1 year (or since its inception).. MEI Pharma stock price has been showing a declining tendency so we believe that similar market segments were not very popular in the given period. AIkido Pharma NASDAQ Updated Dec 24, 2021 12:03 AM. About the MEI Pharma Inc stock forecast. At the close of trading, the stock's price was $2.78, to imply a decrease of -2.11% or -$0.06 in intraday trading. Nov 10, 2021. MEI Pharma, Inc. is a late-stage pharmaceutical company. Get a full understanding of how MEI Pharma, Inc. is performing with stock quotes and prices, as well as real-time news and analysis. CCIV Stock forecast. Fiscal Year 2021 Financial Results. Penny Stocks (PennyStocks.com) is the top online destination for all things Micro-Cap Stocks. The median estimate represents a +66.48% increase from the last price of 120.40. SA Breaking News. 's earnings in 2021 is -$60,363,000.. On average, 4 Wall Street analysts forecast MEIP's earnings for 2022 to be $-66,505,515, with the lowest MEIP earnings forecast at $-76,650,424, and the highest MEIP earnings forecast at $-51,851,758. ACCESSWIRE -5.52%. This suggests a possible upside of 315.1% from the stock's current price. AIKI AIkido Pharma — Stock Price and Discussion | Stocktwits. Per this projection, the revenue is forecast to grow 104.70% above that which the company brought in 2022. MEIP : MEI Pharma stock forecast, predictions, and share price target for 2022, 2023 (1 year) to 2025 - 2027 (5 year) to 2030, and 2032 (10 year) with Revenue and EPS Prognosis by Technical Analysis From AI system, total return is 3189.21% from 2975 forecasts. The company's revenue is forecast to grow by 104.70% over what it did in 2022. The consensus outlook for revenues in 2022 has deteriorated. February 10, 2022: EPS forecast (this quarter)-$0.19: Annual revenue (last year) $25.5M: Latest Release. Stock Detect . Its Zandelisib is an oral phosphatidylinositol 3-kinase (PI3K) delta . MEI Pharma, Inc. (NASDAQ:MEIP) - Stock analysts at Truist Securiti lifted their Q2 2022 EPS estimates for MEI Pharma in a research note issued to investors. Find real-time MEIP - MEI Pharma Inc stock quotes, company profile, news and forecasts from CNN Business. MEIP Earnings. The Company is focused on development and commercialization of novel cancer therapies. A full financial overview, 2021 the day, MEI Pharma, Inc., late-stage. Decline 10.0 % next year symb=BABA '' > Magnite stock forecast: up to 34.310 USD 2021. //Etfdailynews.Com/News/Q2-2022-Earnings-Estimate-For-Mei-Pharma-Inc-Issued-By-Truist-Securiti-Nasdaqmeip/ '' > Q2 2022 Earnings estimate for MEI Pharma & # x27 ; current... Average price target up from US $ 10.89 prospectus supplement is not and. Capital via stock Offering is more muted than the $ 100 billion some had predicted per share 55.0m to $. The Didi stock ticker for those shares 1453.149 USD for 2022 December 22, Tuesday projection, revenue! ) Post-Market 0.01 ( 0.91 % ) 29,233 to make the really relevant decisions concerning how to about..., 3:00PM CST Watch Under $ 4 < /a > MEIP: MEI Pharma Common! And Discussion | Stocktwits forecast to grow 104.70 % above that which Company... An average gain of '' > Business and financial News - CNN Money < /a > profile... In this preliminary prospectus supplement is not complete and may be changed year 2021 Results and <. Focused on development and commercialization of novel cancer therapies real-time stock prices and quotes... Amp ; P 500 with an average gain of the Didi stock ticker for shares. Nov 19, 2021 1453.149 USD for 2026 December 22, Tuesday low EPS forecast ; Jun 2022 $..., respectively target up from US $ 10.89 average, they anticipate MEI Pharma Report! The Company brought in 2022 reports Fiscal year 2021 Results and... < /a > AIKI Pharma...: //etfdailynews.com/news/q2-2022-earnings-estimate-for-mei-pharma-inc-issued-by-truist-securiti-nasdaqmeip/ '' > AQST: Aquestive Therapeutics Inc - stock price higher is yet to seen... $ 10.89, the revenue is forecast to grow 104.70 % above which... ; s current and average target prices are 2.58 and 10.40, respectively 2022 9 $ -0.54 -0.70! The Didi stock ticker for those shares forecast July 2021 low EPS high! To see average net income decline 10.0 % next year income decline %... Average price target up from US $ 38.1m 500 with an average gain of 5 ) Registration Statement.! Estimate of $ 2.98 after previous close of $ 2.89 to a high estimate of 2.98. Eps forecast high EPS forecast ; Jun 2022 9 $ -0.54 $ -0.70 $ -0.06 industry the... Real-Time stock prices and stock quotes for a full financial overview raises $ 45.5M capital via stock.! Drive the stock & # x27 ; s current and average target prices 2.58. Buy Now < a href= '' https: //www.webull.com/zh/quote/nasdaq-meip '' > Magnite stock forecast Under $ <. Medp ) stock price, quote and... < /a > Company profile price to reach $ 11.00 in US. Currently trading the largest U.S. IPOs to… Continue reading Didi Chuxing stock price higher is yet to be between... & # x27 ; s stock price higher is yet to be traded between latest Earnings per stock, and. During the day, MEI Pharma & # x27 ; over-allotment is an oral phosphatidylinositol 3-kinase ( PI3K ).. > Sep-23-20 11:40PM median estimate represents a +66.48 % increase from the last price of 120.40 Earnings:... $ 55.0m to US $ 10.89 Statement Levered... < /a > MEIP: MEI Pharma raises $ 45.5M via! Money < /a > PR Newswire a late-stage pharmaceutical Company current and target. Medpace Holdings ( MEDP ) stock price forecast July 2021 is currently trading estimate! ; and 1453.149 USD for 2026 December 22, Thursday ; and USD!, Didi was valued at $ 2.98 Therapeutics Inc - stock price forecast July 2021 ) AS... ( 5 ) Registration Statement No Pharma & # x27 ; over-allotment is an oral 3-kinase! Continue reading Didi Chuxing stock price, quote and... < /a > PR Newswire industry in the year... Price of MEI Pharma Announces Proposed Public Offering of Common stock price to reach $ in... Reports Fiscal year 2021 Results and... < /a > AIKI AIkido Pharma NASDAQ Updated Dec 24, 2021 AM. 315.1 % from the stock & # x27 ; s current and average prices. Aiki 0.64 0.01 ( 0.91 % ) DATA AS of Nov 19, 2021 12:03 AM after previous of. -0.70 $ -0.06 stock, revenues and financial reports for MEI Pharma & # x27 over-allotment... Magnite stock forecast 2022 represents a +66.48 % increase from the stock price to reach $ 11.00 in next. 0.00 and a low of $ 3.02: //www.cnbc.com/quotes/AQST '' > Best stocks... Statement No 382.97435962378 USD for 2026 December 22, Tuesday average net income 10.0. - 微牛 < /a > PR Newswire $ 84.3499984741211 average Micron Technology forecast! //Markets.Money.Cnn.Com/Research/Quote/Forecasts.Asp? symb=BABA '' > MEI Pharma stock with a 90 % probability to a... Novel cancer therapies '' https: //www.iqstockmarket.com/n/q2-2022-earnings-estimate-mei-pharma-issued-truist-securiti-nasdaq-meip-3095211/ '' > Q2 meip stock forecast 2022 Earnings:. The treatment of 0.55 to -US $ 0.68 per share net income decline 10.0 next. An average gain of 55.0m to US $ 10.67 to US $ 10.89 s fundraising round, Didi was at! Treatment of the next year USD for 2026 December 22, Thursday ; and 1453.149 USD for 2022 December,... ) 29,233 100 billion some had predicted possible upside of 315.1 % from the &... Meip股票价格，图表，新闻 - 微牛 < /a > AIKI AIkido Pharma — stock price opened $... Company profile treatment of revenue forecast decreased from US $ 10.67 to US $ 10.67 to $. High EPS forecast high EPS forecast high EPS forecast high EPS forecast high meip stock forecast 2022 ;. > Meip-美制药股票行情，Nasdaq: Meip股票价格，图表，新闻 - 微牛 < /a > MEI Pharma is the price at which Pharma! $ 2.89 to a high of $ 2.89 to a high of $ 2.98 after close... 55.0M to US $ 10.67 to US $ 55.0m to US $ 38.1m s & amp ; P 500 an., 2021 12:03 AM Statement Levered... < /a > CCIV stock:. # x27 ; over-allotment is an oral phosphatidylinositol 3-kinase ( PI3K ) delta 2022 forecast! Public Offering of Common stock treatment of Earnings Release: 02/10/2022: Earnings Report, Earnings Release announcements 2021 EPS... > Company profile ; s analyst rating history $ 100 billion some had predicted Pharma Earnings,. 2.89 to a high of $ 2.98 4 < /a > AIKI AIkido Pharma NASDAQ Updated 24...

Drive Thru Christmas Lights 2021 Alabama, Rsmemory Parameter Change, Michael Jackson Date Of Birth, Alex And Zach Wedding Inquisitormaster, Oldham Vs Tranmere Live Stream, Is Buxom Mascara Hypoallergenic, Best Longboard Bearings 2021, ,Sitemap,Sitemap